Abstract: The present invention concerns a method for the manufacture of a 5-substituted 2-(alkoxymethyl)furan (or a mixture of such furans) by reacting a starting material comprising at least a 5-substituted furfural with hydrogen in the presence of an alcohol and a catalyst system.
Abstract: Improved apparatus for use in process systems which include exothermic chemical conversions of organic compounds to value added products is disclosed, more particularly, flow reactors for exothermic chemical conversions using a fixed heterogeneous catalyst with means for control of the exotherm.
Type:
Grant
Filed:
February 4, 2011
Date of Patent:
July 31, 2012
Assignee:
BP Corporation North America Inc.
Inventors:
Hassan Taheri, Curtis D. Dickinson, Paul A. Jacobson
Abstract: Described herein are ?9-THC prodrugs, methods of making ?9-THC prodrugs, formulations comprising ?9-THC prodrugs and methods of using ?9-THC. One embodiment described herein relates to the transdermal administration of a ?9-THC prodrug for treating and preventing diseases and/or disorders.
Type:
Grant
Filed:
December 1, 2008
Date of Patent:
July 24, 2012
Assignee:
Alltranz Inc.
Inventors:
Audra Lynn Stinchcomb, Miroslaw Jerzy Golinski, Dana Carmel Hammell, Jeffery Lynn Howard
Abstract: The present invention concerns a process for the preparation of a compound of formula (I), wherein the dotted line is a single bond and n is 1 or the dotted line is a double bond and n is 0, and wherein the relative configuration is as shown, in the form of any one of its diastereoisomers or enantiomers or mixtures thereof.
Abstract: Described herein are C5-C6 annelated naphthopyrans that possess at least one electron-withdrawing group. The compounds possess desirable properties such as increased fading kinetics. Also described herein are new methods for synthesizing 2H-chromenes annelated at C5-C6. The methods involve less stringent reaction conditions as well as provide increased reaction yields. The methods permit the synthesis of a wide variety of substituted naphthopyrans that can be temperature sensitive, which was not possible with previous synthetic routes.
Type:
Grant
Filed:
August 4, 2009
Date of Patent:
July 10, 2012
Assignee:
Corning Incorporated
Inventors:
Suresh Das, Bruno Dufour, Mangalam S Nair, Kokkuvayil V Radhakrishnan
Abstract: A process for the integral production and reactive consumption of hydrogen peroxide combines oxidation of a high-boiling secondary alcohol to form hydrogen peroxide and the ketone analog, recycle of a hydrogenated ketone/alcohol stream to the oxidation step, and epoxidation of unsaturated fatty acid esters utilizing a gaseous hydrogen peroxide stream as it is produced. The epoxidized esters are known to have desirable characteristics for use as plasticizers and similar products.
Abstract: The present invention provides an efficient production method of an optically active cis-silylolefin oxide compound useful as an intermediate for various compounds. A production method of an optically active cis-silylolefin oxide compound by subjecting an optically active cis-silylolefin compound to an asymmetric oxidation with a high enantioselectivity and a high chemical yield by utilizing as a catalyst, an optically active titanium complex of Formula (1), Formula (2): or the like.
Abstract: The present invention relates to compounds useful in the modulation of potassium channel activity in cells, in particular the activity of Kv1.3 channels found in T cells. The invention also relates to the use of these compounds in the treatment or prevention of autoimmune and inflammatory diseases, including multiple sclerosis, pharmaceutical compositions containing these compounds and methods for their preparation.
Type:
Grant
Filed:
October 4, 2007
Date of Patent:
July 10, 2012
Assignee:
Bionomics Limited
Inventors:
Bernard Luke Flynn, Jonathan B. Baell, Andrew J. Harvey, Jason Hugh Chaplin, Dharam Paul, Jorgen Alvar Mould
Abstract: Process for preparing propylene oxide, which comprises at least the steps (i) and (ii): (i) providing a catalyst comprising at least one porous oxidic material; (ii) reacting propene with a hydroperoxide in at least one nitrile as solvent or in a solvent mixture comprising at least one nitrile in the presence of the catalyst of (i), wherein the at least one porous oxidic material is a zeolite which is assigned X-ray-crystallographically to the MWW type.
Type:
Grant
Filed:
September 10, 2009
Date of Patent:
July 3, 2012
Assignee:
BASF Aktiengesellschaft
Inventors:
Ulrich Mueller, Georg Krug, Peter Rudolf, Joaquim Henrique Teles, Hans-Georg Goebbel, Peter Bassler
Abstract: The present invention relates to the industrial production of vinylene carbonate (VC) by eliminating hydrogen chloride from chloroethylene glycol carbonate (CGC) or solid catalysts in the gas phase, the reaction being carried out over a catalyst bed agitated by thorough mixing.
Type:
Grant
Filed:
May 4, 2006
Date of Patent:
June 19, 2012
Assignee:
Saltigo GmbH
Inventors:
Reinhard Langer, Anke Beckmann, Andreas Schulze Tilling, Paul Wagner, Leslaw Mleczko, Sigurd Buchholz
Abstract: This invention relates to a method for stabilizing quercetin by placing it in a solution containing vitamin B3 and vitamin C and assessing stability of the quercetin in the mixture.
Abstract: The present invention provides a 3?,4?,5-trimethoxy flavone derivative and a pharmaceutically acceptable salt thereof, preparation thereof, and a pharmaceutical composition for the treatment and prevention of dry eye syndrome comprising the same as an active ingredient. The 3?,4?,5-trimethoxy flavone derivative and its pharmaceutically acceptable salt inhibit corneal damage through excellent stimulatory action on mucus secretion in the conjunctiva and therefore may be effective as a prophylactic or therapeutic agent for dry eye syndrome.
Type:
Grant
Filed:
June 2, 2008
Date of Patent:
June 19, 2012
Assignee:
Dong-A Pharm. Co., Ltd.
Inventors:
Seul-Min Choi, Kyung-Koo Kang, Dong-Sung Kim, Jeong-Hoon Kim, Byoung-Ok Ahn, Moo-Hi Yoo, Mi-Jeong Seo, Ju-Mi Kim, Yong-Duck Kim, Sun-Woo Jang, Yong-Sung Shon
Abstract: The invention relates to a terpenic composition for use as an anti-micro-organism or anti-viral agent comprising a cyclic terpenic compound obtained from a terpene of the general formula (C5H8)n, n being in the range of 2 to 5; and to a vector-forming organic substance, associated to the said cyclic terpenic compound.
Abstract: Skin brightening compositions based on esters of 5-hydroxy-2-methyl-4H-pyran-4-one. Also disclosed are methods of making the compositions as well as methods of using the compositions.
Type:
Grant
Filed:
April 7, 2010
Date of Patent:
May 22, 2012
Assignee:
Eastman Chemical Company
Inventors:
Michael Fitzpatrick Wempe, Jeffrey Michael Clauson, Liu Deng
Abstract: An integrated process providing for a gas phase hydro-oxidation of an olefin, preferably, propylene, with oxygen in the presence of hydrogen and a catalyst under reaction conditions such as to form a gaseous hydro-oxidation effluent stream containing an olefin oxide product, preferably, propylene oxide, water, unconverted olefin, oxygen, and hydrogen; and further providing for separation and recovery of the olefin oxide product from the effluent stream. The separation involves feeding the hydro-oxidation effluent stream into a first distillation column employing a liquid reflux rectification agent to obtain a first overhead stream containing unconverted olefin, oxygen, and hydrogen, which is recycled to the hydro-oxidation reactor, and a first bottoms stream containing water and the olefin oxide, from which upon further separation a purified olefin oxide product is recovered.
Type:
Grant
Filed:
March 26, 2008
Date of Patent:
May 22, 2012
Inventors:
David Trent, Katherine Pividal, Jon Siddall, Lanny Robbins
Abstract: The invention relates to a novel process for the preparation of certain cyclopropyl carboxylic acid esters and other cyclopropyl carboxylic acid derivatives; a novel process for the preparation of dimethylsulfoxonium methylide and dimethylsulfonium methylide; to the use of certain cyclopropyl carboxylic acid esters in a process for the preparation of intermediates that can be used in the synthesis of pharmaceutically active entities; and to certain intermediates provided by these processes.
Type:
Grant
Filed:
February 8, 2011
Date of Patent:
May 22, 2012
Assignee:
AstraZeneca AB
Inventors:
Adrian Clark, Elfyn Jones, Ulf Larsson, Anna Minidis
Abstract: Embodiments of the present disclosure include processes and systems for recovering alkylene oxide. System embodiments include a stripping section located in an alkylene oxide recovery column to convert a feed stream comprising to a first gas phase portion comprising alkylene oxide, a condensing zone comprising at least a first condenser and a second condenser configured in series, and a reabsorption region located in the alkylene oxide recovery column above the last of the at least two condensers.
Type:
Grant
Filed:
July 24, 2009
Date of Patent:
May 22, 2012
Assignee:
Dow Technology Investments LLC
Inventors:
John F. Szul, James H. Mccain, Floyd L. Pfeffer, Harvey E. Andresen, Phillip R. Fairchild, Kent E. Newman
Abstract: Compounds of formulas I-IV: (I), (II), (III) (IV), wherein: R1 and R4-R23 are independently selected from H and 1-3 carbon lower alkyl; and R2 and R3 are independently selected from H, 1-3 carbon lower O II alkyl, and —C—Ra, wherein Ra is 1-3 carbon lower alkyl. Pharmaceutical compositions, which include any of Compounds I-IV and a pharmaceutically acceptable carrier, methods of inducing tumor cell apoptosis by administering to a patient in need thereof an effective amount of any of Compounds I-IV, and methods for obtaining any of Compounds I-IV by extracting the compound from coral are also provided.
Type:
Grant
Filed:
March 5, 2008
Date of Patent:
May 22, 2012
Assignee:
Rutgers, The State University of New Jersey
Inventors:
Paul Falkowski, Eric H. Andrianasolo, Liti Haramaty, Eileen White, Richard Lutz